A Study to Evaluate the Efficacy and Safety of AD-224

NCT06291207 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

252

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension,Essential

Interventions

DRUG: AD-224A
DRUG: AD-224B
DRUG: AD-224C
DRUG: Placebo of AD-224A
DRUG: Placebo of AD-224B
DRUG: Placebo of AD-224C

Sponsor

Addpharma Inc.